Merriman Curhan Ford
View Older Stories View More Recent Stories
-
Merriman Curhan Ford Maintains a 'Buy' on Fuqi (FUQI); Valuation has Become Extremely Attractive
-
Merriman Curhan Ford Reiterates a 'Buy' on Cree, Inc (CREE)
-
Merriman Curhan Ford Maintains a 'Buy' on Rick’s Cabaret Int’l (RICK); Raises Estimates
-
Merriman Curhan Ford Downgrades Blue Coat Systems (BCSI) to Neutral; Near-Term Limited Upside to $27-30 Range
-
interCLICK (ICLK) Closes 2.88M Common Share Offering
-
Merriman Curhan Ford Downgrades WPCS Int'l (WPCS) to Neutral; Bid Conversion Rates Remain in Flux, Adds Risk to FY10
-
Biogen (BIIB) Must Raise Offer for Facet (FACT) to At Least $22/Share -Merriman
-
interCLICK (ICLK) Prices 2.88M Common Offering at $4.50/Share
-
Merriman Curhan Ford Initiates Coverage on China XD Plastics Co., Ltd. (CXDC) with a Buy
-
AOL (AOL) Takes Flight... Again
-
Notable Analyst Rating Changes 12/10: VALE, TOL, MEE, TROW, DKS Upgraded; NVS, AES, MEE, VIV Downgraded
-
So Far, 2 Neutral's and a Sell on Today's Hot IPO, AOL (AOL)
-
Merriman Curhan Ford Initiates Coverage on AOL, Inc (AOL) with a Sell
-
Notable Analyst Rating Changes 12/04: BAC, SNV, FSLR, AKAM Upgraded; TTWO, SWHC, AKS, NFLX Downgraded
-
Merriman Curhan Ford Downgrades Smith & Wesson Holding (SWHC) to Neutral; Near-Term Outlook Clouded
-
Merriman Curhan Ford Initiates Coverage on CytRx Corporation (CYTR) with a Buy
-
Notable Analyst Rating Changes 12/01: FITB, BPFH, MENT, CLWR, LTD, SPWRA Upgraded; NFLX, NUVA Downgraded
-
Merriman Curhan Ford Downgrades Netflix (NFLX) to Neutral; Risk Lies More With Initial 1Q Guidance
-
Merriman Curhan Ford Initiates Coverage on Procera Networks, Inc. (PKT) with a Buy
-
Unusual 11 Mid-Day Movers 11/18: ABK, LZB, NLST, LDK Higher; ONCY, NANO, EXEL, VRUS Lower
-
Morning Movers 11/18: ABK, CHS, LDK, RDN Higher; ONCY, NANO, EXEL, ADSK, CNQR Lower
-
Compellent Technologies (CML) Prices 3.34M Common Stock Offering at $19.25/Share
-
Merriman Curhan Ford Downgrades Exelixis (EXEL) to Neutral; Valuation Call
-
Analysts Falling Over Each Other to Downgrade SunPower (SPWRA) Following Accounting Investigation
-
Merriman Curhan Ford Downgrades SunPower (SPWRA) Two Notches to Sell; EPS Estimates Under Review
-
Daily State of the Markets: The Buck Stops Where?
-
Merriman Curhan Ford Upgrades Carmike Cinemas (CKEC) to Buy; Recent Dip Presents Attractive Entry Point
-
Merriman Curhan Ford Downgrades Vertex Pharmaceuticals (VRTX) to Neutral; Valuation Call
-
Merriman Curhan Ford Initiates Coverage on Antares Pharma (AIS) with a Buy; Cutting Edge Drug Delivery Business
-
Merriman Curhan Ford (MERR) Reports Large Q3 Loss
-
Unusual 11 Mid-Day Movers 11/16: SPEX, NLST, DRAM, XJT Higher; PARD, CRXX, CAEI, CHIO Lower
-
Oppenheimer, BMO, Merriman, Needham Downgrade Poinard (PARD) Following Negative Picoplatin Data
-
Notable Analyst Rating Changes 11/16: COH, JWN, GNK, ESEA, SVA, YGE Upgraded; PARD, GPS, JCP, DLTR Downgraded
-
Morning Movers 11/16: SPEX, NLST, XJT, NABI, KHD, IBKC, SPA Higher; PARD, CRXX, CAEI Lower
-
Merriman Curhan Ford Downgrades Poniard Pharmaceuticals (PARD) to Neutral After Disappointing Phase III SPEAR Trial Results
-
Merriman Curhan Ford Downgrades ZAGG, Inc. (ZAGG) from Buy to Neutral; 3Q09 Results Were Mixed
-
Compellent Technologies (CML) Files 3M Common Share Offering; 2.7M To Be Sold by Shareholders
-
Merriman Curhan Ford Reiterates a 'Buy' on Regeneron (REGN); Raising Target Range
-
Notable Analyst Rating Changes 11/5: PALM, VALE, TRW, ONNN, MDT, SPWRA Upgraded; CMCSA, ARO, DPTR, GRMN TEX Downgraded
-
Merriman Curhan Ford Initiates Coverage on Isilon Systems (ISLN) with a Neutral
-
Merriman Curhan Ford Initiates Coverage on YM BioSciences (YMI) with a Buy; Intriguing Opportunity
-
Merriman Curhan Ford Downgrades Geeknet (LNUX) to Neutral; Online Media Segment Turnaround Taking Longer Than Expected
-
Merriman Curhan Starts Novavax (NVAX) at Buy, $6-$8 Tgt
-
Merriman Curhan Positive On Celldex Therapeutics (CLDX) After Results and Ahead of Events
-
InterMune (ITMN) Higher Following INFORM-1 Trial Data
-
Merriman Curhan Ford Downgrades Carmike Cinemas (CKEC) to Neutral; Cautious on Near-Term Ability
-
Merriman Curhan Ford Reiterates 'Buy' Geron Corporation (GERN); Important Stem Cell Visibility
-
Notable Analyst Rating Changes 10/28: TXN, MOT, TGT, WYNN, ILMN Upgraded; APOL, SNDK, NVDA, X, VCLK Downgraded
-
Morning Movers 10/28: CSBC, QTM, ANIK, RSYS, PEET, WSII Higher; CALC, KSP, PSYS, VCLK, VPHM, GT Lower
-
Cyclacel Pharmaceuticals (CYCC) Moves Up On Merriman Curhan's New "Buy" Rating, Aggressive Price Target

